U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07942077) titled 'FLASH Biomarker Study' on Oct. 30.

Brief Summary: This is a single-center, non-interventional biospecimen collection protocol that accompanies C-FLASH-01 (Protocol IBA-04-UP, IDE G260113), a pilot trial of ultra-high dose rate proton reirradiation (ConformalFLASH) for head and neck cancer. Blood and saliva will be collected from up to 10 participants enrolled on the C-FLASH-01 trial at three time points: 1) within 4 weeks before the start of radiotherapy, 2) within 3 days of the last day of radiotherapy, and 3) within 4 months after completion of radiotherapy.

Study Start Date: Nov. 01

Study Type: OBSERVATIONAL

Condition: Head a...